Remicade History - Infliximab History
Information on the history of the TNF blocker drug Remicade, generic drug name infliximab.
12/21/2004 Remicade History: Remicade Is Approved For AS
12/21/2004, The FDA has approved Remicade to treat the signs and symptoms of active ankylosing spondylitis.
12/21/2004, The FDA has approved Remicade to treat the signs and symptoms of active ankylosing spondylitis.
08/11/2004 Remicade History: Warning Added To Remicade Label
08/11/2004, Warnings have been added to the Remicade label for hematologic and neurologic events.
08/11/2004, Warnings have been added to the Remicade label for hematologic and neurologic events.
08/05/2004 Remicade History: CDC Reports TB Potential For TNF Blockers
08/05/2004, The FDA has determined that tuberculosis (TB) is a potential adverse reaction from treatment with the tumor necrosis factor-alpha antagonists Remicade, Enbrel, and Humira.
08/05/2004, The FDA has determined that tuberculosis (TB) is a potential adverse reaction from treatment with the tumor necrosis factor-alpha antagonists Remicade, Enbrel, and Humira.
03/07/2003 Remicade History: FDA Panel Scrutinizes Safety Of 4 Drugs
03/07/2003, The risk versus benefit of Arava, Enbrel, Remicade, and Humira was reconsidered.
03/07/2003, The risk versus benefit of Arava, Enbrel, Remicade, and Humira was reconsidered.
10/24/2001 Remicade History: Remicade (Infliximab) Ineffective For CHF
10/24/2001, Remicade (infliximab) maker halts trial designed to assess use for congestive heart failure (CHF).
10/24/2001, Remicade (infliximab) maker halts trial designed to assess use for congestive heart failure (CHF).
11/15/1999 Remicade History: Remicade Approved For RA By FDA
11/15/1999, Remicade (infliximab) was FDA approved for treatment of rheumatoid arthritis.
11/15/1999, Remicade (infliximab) was FDA approved for treatment of rheumatoid arthritis.
06/15/1999 Remicade History: Positive Results ATTRACT Remicade Trial
06/15/1999, Results from ATTRACT clinical trial revealed favorable results for Remicade (infliximab).
06/15/1999, Results from ATTRACT clinical trial revealed favorable results for Remicade (infliximab).